Company Active LTD

Company profile

Catalent Nottingham Limited

Leading Global CDMO for Pharma & Biotech | Catalent

Providing CDMO services, delivery technologies and manufacturing solutions to develop pharmaceuticals, biologics and consumer health products.

CRN
03397582
Founded
1997
Age
29

Overview

Legal name
CATALENT NOTTINGHAM LIMITED
Region
East Midlands
Registered address
8 ORCHARD PLACE
NOTTINGHAM BUSINESS PARK
NOTTINGHAM
NOTTINGHAMSHIRE
NG8 6PX
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

2 levels 1 ultimate controller Controls 2
1
Company Active LTD
Catalent Nottingham Limited
CRN 03397582
2
Direct controller Active LTD
3
Ultimate controller
208737688
CRN 208737688

Company events

Reference milestones and recent Companies House filing stream events.

6 events
15 Nov
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

01 Nov
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

15 Nov
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQ0MzU2MzkyM2FkaXF6a2N4

Published 15 Nov 2024 12:54

30 Jun
2024

Accounts filed

Accounts

Last accounts made up date

03 Jul
1997

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2010
Funded years
2010, 2013, 2014
Age at first award
12 years

Projects

2014 Collaborative R&D

Accelerating paediatric formulation development through smart design and predictive science

1 Jul 2014 to 31 Mar 2018

Awarded
£60,176
Total cost £100,294

This project is a collaboration between large UK pharmaceutical companies, academia and technology suppliers to generate a structured approach to designing age-appropriate medicines for children and technology for predicting their quality and performance. Paediatric medicine is currently a "hot-topic" within the pharmaceutical industry and there is a lot ...

2013 EU-Funded Lead participant

PAT

1 Sep 2013 to 31 Aug 2015

Awarded
£31,248
Total cost £62,495

Awaiting Public Project Summary

2010 Fast Track

Regenerative Matrices for Orthopaedic Repair

1 Jul 2010 to 31 Mar 2011

Awarded
£32,934
Total cost £54,890

Awaiting Public Summary

Product types

Collaborative R&D EU-Funded Fast Track